CD8A and neoplasm: Collectively, TNBCvax vaccination effectively elevated pro-inflammatory and cytotoxic activity of CD4+ and CD8+ T cells and enhanced central memory T cell responses, and resulting in stronger anti-tumor immune responses compared to CpG control group.